Comparison of ETDRS 7-Field to 4-Widefield Digital Imaging in the Evaluation of Diabetic Retinopathy Severity.
Journal
Translational vision science & technology
ISSN: 2164-2591
Titre abrégé: Transl Vis Sci Technol
Pays: United States
ID NLM: 101595919
Informations de publication
Date de publication:
03 01 2022
03 01 2022
Historique:
entrez:
11
1
2022
pubmed:
12
1
2022
medline:
27
1
2022
Statut:
ppublish
Résumé
To compare Early Treatment Diabetic Retinopathy Study (ETDRS) severity levels between two digital fundus imaging protocols for research studies of diabetic retinopathy: the gold standard 7-field (7F) imaging and the more recent 4-widefield (4W) imaging. Two hundred twenty-two participants enrolled in the Diabetes Prevention Program Outcomes Study underwent concurrent 7F and 4W imaging. The ETDRS levels from 220 paired gradable images were determined by masked graders. Each image was graded by two independent graders with adjudication by a senior grader, if necessary. Percent agreement between graders and between imaging protocols was evaluated with kappa statistics and weighted kappa statistics. Of 220 gradable eyes, diabetic retinopathy was seen in 11.8%; this was mild in 10.4% and more than mild in 1.4% using 7F imaging. The ETDRS levels showed exact agreement of 95% between 7F and 4W imaging (weighted kappa 0.86). Intergrader agreement for each modality had exact agreement of 89% (weighted kappa of 0.73) for 7F and 91% (weighted kappa 0.77) for 4W. There is substantial agreement in the ETDRS severity level between the 7F and 4W digital imaging protocols, demonstrating that the two imaging protocols are interchangeable. Both 4W and 7F digital imaging protocols can be used for assessing ETDRS levels, even in populations with minimal diabetic retinopathy. The 4W protocol requires fewer images than the 7F, is more comfortable for the patients, is easier for photographic capture, and provides diabetic retinopathy data that is equivalent to the 7F imaging protocol.
Identifiants
pubmed: 35015059
pii: 2778250
doi: 10.1167/tvst.11.1.13
pmc: PMC8762689
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Research Support, U.S. Gov't, P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
13Subventions
Organisme : NIDDK NIH HHS
ID : U01 DK048412
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK048375
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK048434
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK048413
Pays : United States
Organisme : NCRR NIH HHS
ID : M01 RR016587
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK048339
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK048468
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK048387
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK048404
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK048377
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK048407
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK048437
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK048406
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK048397
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK048381
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK048514
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK048485
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK048411
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK048443
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK048380
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK048400
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK048489
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK048349
Pays : United States
Références
Ophthalmology. 1991 May;98(5 Suppl):786-806
pubmed: 2062513
Arch Ophthalmol. 1994 Sep;112(9):1217-28
pubmed: 7619101
Diabetes Metab Syndr Obes. 2013 Nov 29;6:477-91
pubmed: 24348061
Lancet. 2009 Nov 14;374(9702):1677-86
pubmed: 19878986
Retina. 2018 Oct;38(10):1896-1904
pubmed: 30234859
Diabetes Care. 2014;37(1):17-23
pubmed: 24356593
Diabetes Care. 2009 Nov;32(11):2027-32
pubmed: 19875604
Ophthalmology. 2020 Apr;127(4S):S97-S98
pubmed: 32200832
Ophthalmology. 2017 Jul;124(7):970-976
pubmed: 28336057
Arch Ophthalmol. 2012 Sep;130(9):1145-52
pubmed: 22965590
Arch Ophthalmol. 1995 Nov;113(11):1386-91
pubmed: 7487599
N Engl J Med. 2002 Feb 7;346(6):393-403
pubmed: 11832527
Invest Ophthalmol Vis Sci. 2011 Aug 03;52(9):6168-73
pubmed: 21571677
Ophthalmology. 1991 May;98(5 Suppl):823-33
pubmed: 2062515
Lancet Diabetes Endocrinol. 2017 Jun;5(6):431-437
pubmed: 28365411
Diabetologia. 2009 Jul;52(7):1279-89
pubmed: 19387611
Ophthalmology. 1986 May;93(5):586-9
pubmed: 3725317
Diabetes Care. 1999 Apr;22(4):623-34
pubmed: 10189543
Biometrics. 1977 Mar;33(1):159-74
pubmed: 843571
Diabetes Care. 2019 Sep;42(9):1809-1815
pubmed: 31320445
Lancet Diabetes Endocrinol. 2015 Nov;3(11):866-75
pubmed: 26377054